NVCR
Novocure Ltd · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -8.5% · neue Nettopositionen 0.0% · Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 119.64K | $1.43M | n/a | n/a |
| Q2 2026 | 91 | +1 | 75.35M | $1.14B | +7 | −6 |
| Q1 2026 | 93 | -1 | 69.74M | $759.20M | +6 | −7 |
| Q4 2025 | 93 | -2 | 74.88M | $967.62M | n/a | −2 |
| Q3 2025 | 19 | 0 | 56.46M | $729.50M | n/a | n/a |
| Q2 2025 | 16 | +1 | 59.30M | $1.06B | +2 | −1 |
| Q1 2025 | 12 | -3 | 16.40M | $292.30M | n/a | −3 |
| Q4 2024 | 15 | +1 | 16.08M | $479.25M | +1 | n/a |
| Q3 2024 | 13 | 0 | 14.54M | $227.34M | n/a | n/a |
| Q2 2024 | 13 | n/a | 14.57M | $249.63M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 16.77M | +0.3% | $216.67M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | BlackRock ✦ (passiv) | 13.95M | -1.2% | $180.20M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 3 | The Vanguard Group ✦ (passiv) | 10.46M | -2.8% | $135.09M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 4 | State Street Global Advisors ✦ (passiv) | 2.61M | -2.5% | $33.73M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (passiv) | 2.47M | +1.2% | $31.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Capital World Investors ✦ | 2.00M | -68.7% | $25.84M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Millennium Management ✦ | 1.34M | +106.5% | $17.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Baillie Gifford ✦ | 1.12M | -0.4% | $14.52M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 9 | Renaissance Technologies ✦ | 1.07M | -17.5% | $13.86M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 10 | Marshall Wace ✦ | 1.03M | -26.8% | $13.37M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 916.15K | n/a | $11.84M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 12 | Goldman Sachs Group ✦ | 904.51K | n/a | $11.69M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | JPMorgan Chase ✦ | 564.37K | n/a | $7.29M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 14 | D. E. Shaw & Co. ✦ | 486.48K | +2266.6% | $6.29M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 15 | Citadel Advisors ✦ | 223.56K | -75.0% | $2.89M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 196.82K | +478.9% | $2.54M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 17 | Two Sigma Investments ✦ | 117.37K | -39.9% | $1.52M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 116.60K | -75.2% | $1.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 110.31K | +4.3% | $1.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 221 Inhaber, 97.96M Anteile, $1.02B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.